Global Water Resources, Inc. (GWRS)

Sage Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	53.54	52.69	53.03	44.73	41.91	38.63
Revenue Growth (YoY)	3.94%	-0.63%	18.56%	6.71%	8.51%	8.90%
Operations & Maintenance	14.13	13.73	12.67	10.89	10.3	7.14
Selling, General & Admin	16.94	16.88	16.64	16.13	15.15	12.72
Depreciation & Amortization	13.11	12.72	11.44	9.89	9.49	9.03
Other Operating Expenses	-	-	-	-	-	2.4
Total Operating Expenses	44.19	43.33	40.74	36.91	34.94	31.29
Operating Income	9.35	9.36	12.29	7.82	6.98	7.34
Interest Expense	-6.01	-6.1	-4.88	-4.76	-5.2	-5.38
Interest Income	0.81	0.95	0.05	0.07	0.02	0.09
Net Interest Expense	-5.2	-5.15	-4.83	-4.69	-5.18	-5.28
Allowance for Borrowed Funds for Construction	-	-	-	0.72	-	-
Other Non-Operating Income (Expenses)	3.86	3.96	3.34	2.59	1.46	0.33
EBT Excluding Unusual Items	8	8.17	10.79	6.44	3.26	2.38
Gain (Loss) on Sale of Assets	-0.31	-0.31	0.06	-	1.5	-0.5
Pretax Income	7.7	7.86	10.85	6.44	4.76	1.88
Income Tax Expense	2.01	2.07	2.87	0.93	1.15	0.77
Net Income	5.69	5.79	7.98	5.51	3.61	1.11
Net Income to Common	5.69	5.79	7.98	5.51	3.61	1.11
Net Income Growth	-8.34%	-27.47%	44.97%	52.56%	226.61%	-50.31%
Shares Outstanding (Basic)	24	24	24	23	23	23
Shares Outstanding (Diluted)	24	24	24	23	23	23
Shares Change (YoY)	0.58%	0.72%	3.42%	1.88%	1.46%	4.84%
EPS (Basic)	0.23	0.24	0.33	0.24	0.16	0.05
EPS (Diluted)	0.23	0.24	0.33	0.24	0.16	0.05
EPS Growth	-10.70%	-27.52%	38.88%	48.92%	225.15%	-50.93%
Free Cash Flow	-20.59	-10.54	3.08	-10.65	2.14	5.44
Free Cash Flow Per Share	-0.85	-0.43	0.13	-0.46	0.09	0.24
Dividend Per Share	0.297	0.301	0.300	0.300	0.290	0.290
Dividend Growth	-4.13%	0.40%	-	3.45%	-	-
Profit Margin	10.63%	10.99%	15.05%	12.31%	8.61%	2.86%
Free Cash Flow Margin	-38.45%	-20.00%	5.81%	-23.81%	5.10%	14.07%
EBITDA	22.47	22.08	23.72	17.71	16.47	16.37
EBITDA Margin	41.96%	41.91%	44.74%	39.59%	39.29%	42.37%
D&A For EBITDA	13.11	12.72	11.44	9.89	9.49	9.03
EBIT	9.35	9.36	12.29	7.82	6.98	7.34
EBIT Margin	17.47%	17.77%	23.17%	17.48%	16.65%	18.99%
Effective Tax Rate	26.07%	26.37%	26.46%	14.50%	24.16%	41.10%
Revenue as Reported	53.54	52.69	53.03	44.73	41.91	38.63

Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Utility template. Financial Sources.

SEC Filings: 10-K · 10-Q